Clinical Trial Update: Dolutegravir Pharmacokinetics During Weekly Rifapentine/Isoniazid for TB Prevention [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetics study assessing dolutegravir when co-administered with weekly rifapentine/isoniazid for TB prevention in pediatric patients with HIV in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Latent Tuberculosis Infection

Drugs mentioned

• Tivicay (dolutegravir)

Snippet

Sponsor: Brigham and Women's Hospital | Conditions: Pediatric HIV Infection, Latent Tuberculosis | Phase 1 | Status: RECRUITING